ARCHIVES

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

This article is from The Cancer Letter archive.

Vol. 40 No. 06 | February 7, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Clarkson, Freireich Head AACR, ASCO; Oncology Nursing Society Membership Total Now 2,369

June 6, 1980

Only 10% Of Breast Cancer Patients May Benefit From Contralateral Mastectomy

March 26, 2010

NCABP “Anyone With Same Facts Would Have Come To Same Conclusion

October 28, 1994

Data Falsification Charge To Be Aired

June 27, 1980

8 Centers Awarded Comprehensive Designation

February 15, 1991

FDA, CMS Take Second Look at Drugs Given “Accelerated” Approval for Cancer

March 21, 2003